Evidence map›Paper›PMID 31214551›Full record

ArticleCanadian journal of gastroenterology & hepatology2019

High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?

Jerônimo De Conto Oliveira, Enrique Carrera, Roberta C Petry, Caroline Deutschendorf, Augusto Mantovani, Samantha Thifani Alrutz Barcelos, Santiago Cassales, Fernando Comunello Schacher, Antônio Barros Lopes, Mario R Alvares-da-Silva

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. One Year After First Spontaneous Bacterial Peritonitis: Who Survives?Journal of clinical and translational hepatology · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jerônimo De Conto OliveiraPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0001-8540-3068
Enrique CarreraWorld Gastroenterology Organization Porto Alegre Training Center, Porto Alegre, Brazil.
Roberta C PetryPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Caroline DeutschendorfInfectious Disease Control Commission, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Augusto MantovaniDivision of Gastroenterology and Hepatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Samantha Thifani Alrutz BarcelosPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Santiago CassalesPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Fernando Comunello SchacherPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Antônio Barros LopesDivision of Gastroenterology and Hepatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Mario R Alvares-da-SilvaPost-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.ORCID 0000-0002-5001-246X
Universidade Federal do Rio Grande do Sul · BRHospital de Clínicas de Porto Alegre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Spontaneous bacterial peritonitis (SBP) has a deleterious clinical impact in end-stage liver disease, and multidrug resistance has increased, raising concern about effectiveness of traditional antibiotic regimens. Patients and Methods: Single-center retrospective study of ascitic fluid infections in cirrhotic patients. Results: We analyzed medical records related to 2129 culture-positive ascitic fluid and found 183 samples from cirrhotic patients. There were 113 monobacterial SBP cases from 97 cirrhotic patients; 57% of patients were male; hepatitis C and alcohol were the main etiologies for cirrhosis. Multidrug resistant bacteria were isolated in 46.9% of SBP samples, and third-generation cephalosporin and quinolone resistant reached 38.9% and 25.7% of SBP cases. Conclusion: SBP due to multidrug resistant bacteria is a growing problem, and one should consider reported resistance profiles for the decision-making process of empirical first-line treatment prescription.

Indexed as

Drug Resistance, Multiple, BacterialAdultAgedAnti-Bacterial AgentsAscitic FluidBacterial InfectionsFemaleHumansLiver CirrhosisMaleMiddle AgedPeritonitisPrevalenceRetrospective StudiesAnti-Bacterial Agents

Identifiers

PMID31214551
PMCPMC6535816
OpenAlexW2945202373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.